Skip to main content
Clinical Trials/NCT03054922
NCT03054922CompletedPhase 3

Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables

Nationwide Children's Hospital1 site in 1 country59 target enrollmentStarted: February 23, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
59
Locations
1
Primary Endpoint
Change in Base Deficit

Study Overview

Brief Summary

During major surgical procedures, intravascular volume is maintained with the administration of isotonic fluids such as Lactated Ringers (LR), Normal Saline (NS) or Normosol-R. All three of these fluids are in common clinical use for this purpose. As large volumes of NS may result in a dilutional acidosis and an increasing base deficit, it may cloud clinical decision making when resuscitative efforts are guided by acid-base status on routine arterial blood gas analysis. This is a prospective, randomized study to evaluate changes in acid-base and electrolyte (sodium, potassium, calcium) status with the use of various isotonic fluids for intraoperative resuscitation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
10 Years to 21 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Major surgical procedure requiring arterial access

Exclusion Criteria

  • Comorbid disease process that contraindicates the use of any 1 of the 3 crystalloid solutions.

Arms & Interventions

Normal Saline

Active Comparator

0.9% Sodium Chloride

Intervention: Normal Saline (Drug)

Lactated Ringers

Active Comparator

Each 100 mL of Lactated Ringer's Injection USP contains:

Sodium Chloride USP 0.6 g; Sodium Lactate USP 0.31 g; Potassium Chloride USP 0.03 g; Calcium Chloride Dihydrate USP 0.02 g; Water for Injection USP qs

Intervention: Lactated Ringer (Drug)

Normosol-R

Active Comparator

Each 100 mL of Normosol-R contains sodium chloride, 526 mg; sodium acetate, 222 mg; sodium gluconate, 502 mg; potassium chloride, 37 mg; magnesium chloride hexahydrate, 30 mg.

Intervention: Normosol-R Inj (Drug)

Outcomes

Primary Outcomes

Change in Base Deficit

Time Frame: During surgery (typically 4-6 hrs in length)

Change in base deficit from 1st to 2nd blood gas to measure metabolic acidosis

Secondary Outcomes

  • Change in Sodium(During surgery (typically 4-6 hrs in length))
  • Change in Potassium(During surgery (typically 4-6 hrs in length))
  • Change in pH(During surgery (typically 4-6 hrs in length))
  • Change in Ionized Calcium(During surgery (typically 4-6 hrs in length))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

David P. Martin

Director, Acute Pain Services

Nationwide Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials

Impact of Intraoperative Fluid Management... | Clinical Trial